Purpose: To describe the presentation and clinical course of septic sh
ock due to Toxoplasma gondii in patients infected with the human immun
odeficiency virus (HIV). Patients and methods: From April 1988 to Febr
uary 1992, nine HIV-infected patients were admitted because of predomi
nant septic shock (7 patients) or developed septic shock in the ICU (2
patients). The recent CD4 + cell count ranged from 2 to 84 x 10(6)/L.
Results: The main clinical features were (1) a history of fever for l
onger than 15 days, with a recent increase to more than 39.5-degrees-C
; (2) a recent history of dyspnea (<15 days, 8 cases; <7 days, 3 cases
); and (3) recent onset of thrombocytopenia (6 of 9 cases). All patien
ts were in shock (hyperkinetic profile in 6 of 7; hypokinetic in 1 of
7), and 8 of 9 were in respiratory distress (ratio of PaO2 over fracti
onal concentration of oxygen in the inspired gas of 117+/-23; range, 8
8 to 155). Chest roentgenograms revealed diffuse alveolar infiltrates
in six of nine cases. The serum lactate dehydrogenase (LDH) activity w
as 6,510-5,080 IU/L (range, 1,010 to 15,450 IU/L). Serologic tests for
T gondii were negative in two cases. Toxoplasma gondii was isolated f
rom lung (9/9), bone marrow (5/7), or blood (2/2). One, 3, and 2 patie
nts had brain, ocular, and myocardial involvement, respectively. No ot
her microbial pathogens were isolated. Seven patients died, 5 less tha
n 3 days after admission. Conclusion; Disseminated toxoplasmosis can c
ause septic shock in HIV-infected patients. In two cases, the disease
was probably a primary infection. The association of high fever, acute
dyspnea, recent onset of thrombocytopenia, and a very high level of L
DH activity is suggestive of disseminated toxoplasmosis.